Skip Navigation Links
   
Skip Navigation Links
   

GI - Colon Cancer

GI - Colon Cancer Trials in St. Louis, MO

MATCH: Molecular analysis for therapy choice. Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors or lymphoma.  EAY131 (NCT02465050)  (MBMC Contact: Henry Robinson 314-996-5865)

Companion study to MATCH - COMET:  Communication and Education in Tumor Profiling - A randomized study of pre-disclosure genetic education vs usual care in tumor profiling for advanced cancer and a pilot study of remote genetic counseling for participants with potential germline mutations identified on tumor profiling.  

Phase III study of BBI-608 in combination with 5-fluouracil, leucovorin, irinotecan (FOLFIRI) in adults with previously treated metastatic colorectal cancer.  CANSTEM 303C (NCT02753127)  (MBMC Contact:  Henry Robinson (314-996-5865)  MBMC ONLY

 Implementation of a prospective financial impact assessment tool in patients with metastatic colorectal cancer S1417CD (NCT02728804)  (MBMC Contact:  Henry Robinson 314-996-5865)

 

 

 

 

 

 
 

All contents 2007 Heartland Cancer Research St. Louis, MO. All rights reserved. Privacy Policy